Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus

American Journal of Gastroenterology

Volumn 94, Issue 12, 1999, Pages 3420-3426

  Weston, Allan P ^a,b   Badr, Adnan S ^a,b   Hassanein, Ruth S ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; DISEASE COURSE; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REMISSION;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; EPITHELIUM; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HERNIA, HIATAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REMISSION, SPONTANEOUS;

EID: 0032763960     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00662-0     Document Type: Article

References (43)

1. Haggitt R.C. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 25:1994;982-993.
2. Sagar PM, Ackroyd R, Hosie KB, et al. Regression and progression of Barrett's oesophagus after antireflux surgery.Br J Surg 195;82:806-10.
3. Skinner D.B., Walther B.C., Riddell R.H., et al. Barrett's esophagus, comparison of benign and malignant cases. Ann Surg. 198:1983;554-566.
4. Attwood S.E.A., Barlow A.P., Norris T.L., et al. Barrett's oesophagus Effect of antireflux surgery on symptom control and development of complications . Br J Surg. 79:1992;1050-1053.
5. Ortiz A., Martinze de Haro L.F., Parilla P., et al. Conservative treatment versus antireflux surgery in Barrett's esophagus Long term results of a prospective study . Br J Surg. 83:1996;274-278.
6. Williamson W.A., Ellis F.H., Gubb S.P., et al. Effective antireflux operation on Barrett's mucosa. Ann Thorac Surg. 49:1990;537-542.
7. Bologna S.D., Blumenkehl M., Wong D., et al. Barrett's esophagus response to long term omeprazole therapy. Gastrointest Endosc. 38:1992;229.
8. Caldwell M.T.P., Byrne P.J., Walsh T.N., et al. A randomized trial on the effect of acid suppression on regression of Barrett's oesophagus. Gastroenterology. 110:1996;A74.
9. Gore S., Healey C.J., Sutton R., et al. Regression of columnar lined (Barrett's oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther. 7:1993;623-628.
10. Sampliner R.E. Effect of up to three years of high dose lansoprazole on Barrett's. Am J Gastroenterol. 89:1994;1844-1848.
11. LeRhun M., Boyer J., Goldfian D., et al. Long term omeprazole effects on Barrett's mucosa. Gastroenterology. 110:1996;A174.
12. Neumann C.A., Iqbal T.H., Cooper B.T. Long term continuous omeprazole treatment of patients Barrett's esophagus. Aliment Pharmacol Ther. 9:1995;451-454.
13. Shaffer R.T., Francis J., Carrougher J.G., et al. Effect of omeprazole on Barrett's epithelium after 3 yr of therapy. Esophageal Gastric Duodenal Disord. 110:1996;A255.
14. Weinstein W.M., Lieberman D.A., Lewin K.J., et al. Omeprazole-induced regression of Barrett's esophagus A 2 yr randomized controlled double blind trial . Gastroenterology. 110:1996;A294.
15. Malesci A., Savarino V., Zentilin P., et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc. 44:1996;700-705.
16. Hetzel D.J., Dent W.J., Reed W.D., et al. Healing and relapse of severe peptic esophagitis after treatment with ompeprazole. Gastroenterology. 95:1988;903-912.
17. Weston A.P., Krmpotich P., Makdisi W.F., et al. Short segment Barrett's esophagus Clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia . Am J Gastroenterol. 91:1996;981-986.
18. Hayward J. The lower end of the esophagus. Thorax. 16:1961;36-41.
19. Gottfried M.R., McClave S.A., Boyce H.W. Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus). Am J Clin Pathol. 92:1989;741-746.
20. McClave S.A., Boyce H.W. Jr, Gottfried M.R. Early diagnosis of columnar-lined esophagus a new endoscopic diagnostic criterion . Gastrointest Endosc. 33:1987;413-416.
21. Bombeck C.T., Dillard D.H., Nyhus L.M. Muscular anatomy of the gastroesophageal junction and role of phrenoesophageal ligament. Ann Surg. 164:1966;643-654.
22. Hassall E. Barrett's esophagus New definition and approach in children . J Pediatr Gastroenterol Nutr. 16:1993;345-364.
23. Woolf G.M., Riddell R.H., Irvine E.J., et al. A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. Gastrointest Endo. 35:1989;541-544.
24. Krevsky B., Horwitz B., Miller L.S., et al. Improved visualization of Barrett's esophagus using Lugol's iodine staining during endoscopy. Am J Gastroenterol. 92:1997;1595.
25. Filipe MI. The histochemistry of intestinal mucins. Changes in disease. In: Whitehead, ed. GI and oesophageal pathology, 1st ed. Edinburgh: Churchill Livingstone, 1989:65-89.
26. Spicer S.S. Diamine methods for differentiating mucosubstances histochemically. J Histochem Cytochem. 13:1965;211-234.
27. Schmidt H.G., Riddell R.H., Walther B., et al. Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol. 110:1985;145-152.
28. Riddell R.H., Goldman H., Ransohoff D.F., et al. Dysplasia in inflammatory bowel disease Standardized classification with provisional clinical implications . Human Pathol. 14:1983;931-968.
29. Sharma P., Sampliner R.E., Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol. 92:1997;582-585.
30. Bozymski E.M., Shaheen N.J. Barrett's esophagus Acid suppression but no regression . Am J Gastroenterol. 92:1997;556-557.
31. Heine K.J., Mittal R.K. Crural diaphragm and lower esophageal sphincter as antireflux barriers. Viewpoints Dig Dis. 23:1991;1-6.
32. Orlando R.C. Reflux esophagitis. Yamada T., Alpers D.H., Owyang C., Powell D.W., Silverstein F.E. Textbook of gastroenterology. 2nd ed. 1995;1214-1242 J.B. Lippincott Company, Philadelphia.
33. Sloan S., Kahrilas P.J. Impairment of esophageal emptying with hiatal hernia. Gastroenterology. 100:1991;596-605.
34. Jones M.P., Sloan S., Kahrilas P.J., et al. Hiatal hernia (HH) size is the principal determinant of esophagitis in patients with symptomatic gastroesophageal reflux disease. Gastroenterology. 114:1998;A163.
35. Loughney T., Maydonovitch C.L., Wong R.K. Esophageal manometry and 24-h pH monitoring in patients with short and long segment Barrett's esophagus. Am J Gastroenterol. 93:1998;916-919.
36. Sontag S.J., Schnell T., Chejfec G., et al. Length of Barrett's epithelium corresponds directly to esophageal acid contact time in patients with reflux. Gastroenterology. 110:1996;A262.
37. MacKay C.K., Ihmaidat H., Gong J., et al. Esophageal acid and bile exposure in short segment Barrett's esophagus. Gastroenterology. 112:1997;A205.
38. Humphries T.J. Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus. J Clin Gastroenterol. 9:1987;28-32.
39. Wesdorp I.C.E., Bartelsman J., Schipper M.E., et al. Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus. Gut. 22:1981;724-727.
40. Sampliner R.E., Garewal H.S., Fennerty M.B., et al. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci. 35:1990;93-96.
41. Berenson M.M., Johnson T.D., Markowitz N.R., et al. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology. 104:1993;1688-1691.
42. Levine D.S., Haggitt R.C., Rabinovitch P.S., et al. Complete regression of high-grade dysplasia, DNA content abnormalities and Barrett's esophagus. Gastroenterology. 108:1996;A496.
43. Inoue H. Endoscopic mucosal resection for short-segment Barrett's esophagus as a total biopsy and treatment. ASGE Video Forum. Monday May 18th, 1998. Digestive Disease Week, New Orleans.